These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14873311)

  • 21. [Titration of the virus of tick encephalitis and virus neutralizing antibodies in human embryo fibroblast culture by the phenomenon of interference with poliomyelitis virus].
    AL'TSHTEIN AD
    Vopr Virusol; 1962; 7():529-34. PubMed ID: 14011601
    [No Abstract]   [Full Text] [Related]  

  • 22. Neutralizing antibody to viruses of poliomyelitis in sera of domestic animals.
    BARTELL P; KLEIN M
    Proc Soc Exp Biol Med; 1955 Dec; 90(3):597-601. PubMed ID: 13289848
    [No Abstract]   [Full Text] [Related]  

  • 23. MIRKOVIC RR: Studies on poliomyelitis in Serbia. I. Survey of neutralizing antibodies to polio virus in Serbia in 1954, and isolation of virus 1952-1954.
    MILOVANOVIC MV
    Acta Med Iugosl; 1960; 14():446-65. PubMed ID: 13770993
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies in the epidemiology of poliomyelitis in an island community. III. Development of neutralising antibodies against the three types of poliomyelitis virus during an epidemic.
    OKER-BLOM N; STRANDSTROM H
    Ann Med Exp Biol Fenn; 1956; 34(2):186-98. PubMed ID: 13381989
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparative study of various methods of titration of virus-neutralizing antibodies to poliomyelitis virus in tissue culture].
    GINSBURG NN; KASYMOV KT; AL'TSHTEIN AD
    Vopr Virusol; 1960; 5():20-5. PubMed ID: 13850244
    [No Abstract]   [Full Text] [Related]  

  • 26. A survey of poliovirus neutralizing antibody in Newfoundland, 1959-60.
    OZERE RL; ROZEE KR
    Can Med Assoc J; 1961 Jul; 85(2):63-7. PubMed ID: 13731845
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of antibody in experimental poliomyelitis; reproducibility of endpoint in a mouse neutralization test with Lansing poliomyelitis virus.
    MORGAN IM
    Am J Hyg; 1947 May; 45(3):372-8. PubMed ID: 20240022
    [No Abstract]   [Full Text] [Related]  

  • 28. [Research on neutralizing antibodies to poliomyelitis virus in the district of Asmaria, Ethiopia].
    GARCIA-GANCEDO A; STOFOROS E; FELICI A
    Rend Ist Sup Sanit; 1961; 24():815-9. PubMed ID: 13896847
    [No Abstract]   [Full Text] [Related]  

  • 29. Level of serum antibody associated with intracerebral immunity in monkeys vaccinated with Lansing poliomyelitis virus.
    MORGAN IM
    J Immunol; 1949 Jul; 62(3):301-10. PubMed ID: 18132343
    [No Abstract]   [Full Text] [Related]  

  • 30. The neutralization of the mouse-adapted Lansing strain of poliomyelitis virus by the serum of patients and contacts.
    BROWN GC; FRANCIS T
    J Immunol; 1947 Sep; 57(1):1-10. PubMed ID: 20264681
    [No Abstract]   [Full Text] [Related]  

  • 31. Neutralizing antibody to polioviruses in normal human urine.
    LERNER AM; REMINGTON JS; FINLAND M
    J Clin Invest; 1962 Apr; 41(4):805-15. PubMed ID: 14464245
    [No Abstract]   [Full Text] [Related]  

  • 32. Poliomyelitis virus neutralizing antibodies determination by filter paper discs on solidified bottle cultures.
    DE SOMER P; PRINZIE A
    Virology; 1957 Oct; 4(2):387-8. PubMed ID: 13496554
    [No Abstract]   [Full Text] [Related]  

  • 33. The growth curve of the Lansing strain of poliomyelitis virus in the central nervous system of the mouse.
    AINSLIE JD
    J Exp Med; 1952 Jan; 95(1):1-7. PubMed ID: 14907955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Geographical distribution of neutralizing antibody against poliomyelitis virus "Lansing" strain on human sera collected in various parts of Japan.
    KITAOKA M; MIURA T
    Jpn J Med; 1951 Aug; 4(4):215-21. PubMed ID: 14907188
    [No Abstract]   [Full Text] [Related]  

  • 35. Reversibility of the reaction between polio-virus and neutralizing antibody of rabbit origin.
    MANDEL B
    Virology; 1961 Jul; 14():316-28. PubMed ID: 13766052
    [No Abstract]   [Full Text] [Related]  

  • 36. Failure to demonstrate antibody in feces of monkeys vaccinated with poliomyelitis virus, Lansing strain.
    AINSLIE JD; McCALLUM JL; FRANCIS T
    Proc Soc Exp Biol Med; 1950 Dec; 75(3):699-703. PubMed ID: 14808371
    [No Abstract]   [Full Text] [Related]  

  • 37. Blocking of neutralizing antibody by noninfective poliovirus from proflavine-treated HeLa cells.
    LEDINKO N
    Virology; 1959 Aug; 8():536-9. PubMed ID: 14415148
    [No Abstract]   [Full Text] [Related]  

  • 38. A mouse neutralization test for Lansing poliomyelitis antibody employing a small amount of whole blood.
    KOKKO UP; HOLLANDER DH; TURNER TB
    Am J Hyg; 1953 Nov; 58(3):377-84. PubMed ID: 13104395
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on passive immunity in poliomyelitis. I. Some observations on the production of an immune serum to Lansing poliomyelitis virus in the horse.
    RHODES AJ; CLARK EM; SHIMADA FT
    Can J Public Health; 1951 Jan; 42(1):23-31. PubMed ID: 14801743
    [No Abstract]   [Full Text] [Related]  

  • 40. [Dynamics of secretory and serum immunoglobulins in children in the course of vaccinations with live poliomyelitis monovaccines].
    Shmel'kov IuA; Zhevandrova VI; Drozdov SG
    Vopr Virusol; 1978; (3):332-6. PubMed ID: 358597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.